Ipswich Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
2,835
-582
-17% -$50.9K 0.05% 166
2026
Q1
$291K Hold
3,417
0.07% 158
2025
Q4
$270K Sell
3,417
-613
-15% -$48.1K 0.06% 156
2025
Q3
$322K Sell
4,030
-6,175
-61% -$527K 0.08% 145
2025
Q2
$928K Sell
10,205
-1,247
-11% -$114K 0.22% 91
2025
Q1
$1.07M Sell
11,452
-450
-4% -$40.3K 0.27% 78
2024
Q4
$1.08M Sell
11,902
-960
-7% -$91.6K 0.26% 80
2024
Q3
$1.34M Sell
12,862
-3,000
-19% -$306K 0.31% 72
2024
Q2
$1.54M Sell
15,862
-849
-5% -$78.3K 0.36% 62
2024
Q1
$1.5M Sell
16,711
-240
-1% -$20.3K 0.35% 70
2023
Q4
$1.35M Buy
16,951
+67
+0.4% +$5.04K 0.34% 69
2023
Q3
$1.2M Sell
16,884
-2,175
-11% -$163K 0.33% 71
2023
Q2
$1.47M Sell
19,059
-1,423
-7% -$110K 0.39% 67
2023
Q1
$1.54M Sell
20,482
-640
-3% -$47.6K 0.42% 67
2022
Q4
$1.66M Sell
21,122
-538
-2% -$40.3K 0.48% 62
2022
Q3
$1.52M Sell
21,660
-267
-1% -$20.9K 0.48% 64
2022
Q2
$1.76M Sell
21,927
-291
-1% -$22.8K 0.51% 61
2022
Q1
$1.69M Buy
22,218
+390
+2% +$30.9K 0.42% 68
2021
Q4
$1.86M Sell
21,828
-1,600
-7% -$125K 0.43% 68
2021
Q3
$1.77M Sell
23,428
-1,068
-4% -$84.8K 0.45% 65
2021
Q2
$1.99M Buy
24,496
+339
+1% +$27.7K 0.51% 58
2021
Q1
$1.9M Buy
24,157
+440
+2% +$34.5K 0.54% 59
2020
Q4
$2.03M Buy
23,717
+33
+0.1% +$2.73K 0.61% 53
2020
Q3
$1.83M Sell
23,684
-206
-0.9% -$15.7K 0.59% 54
2020
Q2
$1.75M Sell
23,890
-1,803
-7% -$128K 0.6% 52
2020
Q1
$1.71M Sell
25,693
-175
-0.7% -$12.3K 0.67% 48
2019
Q4
$1.78M Sell
25,868
-700
-3% -$47.7K 0.52% 55
2019
Q3
$1.95M Sell
26,568
-1,865
-7% -$135K 0.62% 52
2019
Q2
$2.04M Sell
28,433
-441
-2% -$31.3K 0.65% 48
2019
Q1
$1.98M Buy
28,874
+366
+1% +$23.6K 0.65% 47
2018
Q4
$1.7M Sell
28,508
-664
-2% -$41.5K 0.62% 49
2018
Q3
$1.95M Sell
29,172
-660
-2% -$44K 0.66% 53
2018
Q2
$1.93M Sell
29,832
-249
-0.8% -$16.3K 0.89% 44
2018
Q1
$2.16M Sell
30,081
-139
-0.5% -$10K 0.91% 38
2017
Q4
$2.28M Sell
30,220
-574
-2% -$41.9K 0.97% 33
2017
Q3
$2.24M Buy
30,794
+516
+2% +$37.2K 1.01% 33
2017
Q2
$2.25M Sell
30,278
-12,679
-30% -$941K 1.05% 33
2017
Q1
$3.14M Sell
42,957
-50
-0.1% -$3.5K 1.37% 26
2016
Q4
$2.81M Buy
43,007
+8,026
+23% +$550K 1.27% 29
2016
Q3
$2.59M Sell
34,981
-789
-2% -$58.3K 1.27% 30
2016
Q2
$2.62M Buy
35,770
+101
+0.3% +$7.19K 1.3% 30
2016
Q1
$2.56M Sell
35,669
-13,931
-28% -$927K 1.22% 31
2015
Q4
$3.3M Hold
49,600
1.49% 25
2015
Q3
$3.15M Sell
49,600
-330
-0.7% -$21.6K 1.5% 25
2015
Q2
$3.27M Hold
49,930
1.47% 24
2015
Q1
$3.46M Sell
49,930
-2,505
-5% -$173K 1.52% 21
2014
Q4
$3.63M Buy
52,435
+3,725
+8% +$252K 1.55% 21
2014
Q3
$3.18M Sell
48,710
-2,080
-4% -$137K 1.35% 32
2014
Q2
$3.46M Buy
50,790
+4,700
+10% +$315K 1.34% 30
2014
Q1
$2.99M Sell
46,090
-2,735
-6% -$172K 1.29% 32
2013
Q4
$3.18M Sell
48,825
-455
-0.9% -$29.1K 1.33% 31
2013
Q3
$2.92M Buy
49,280
+70
+0.1% +$4.15K 1.31% 31
2013
Q2
$2.82M Buy
+49,210
New +$2.92M 1.22% 33

Other funds holding CL

Ipswich Investment Management's CL Position: Q2 2026 in Review

Ipswich Investment Management reduced its Colgate-Palmolive (CL) stake by 17% in Q2 2026, selling an estimated $50.9K and leaving 2,835 shares worth $260K. The position accounts for 0.05% of the portfolio, ranked #166.

Ipswich Investment Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.63M in Q4 2014. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Ipswich Investment Management held 2,835 shares of Colgate-Palmolive worth $260K as of Q2 2026.
  • Ipswich Investment Management sold 582 Colgate-Palmolive shares in Q2 2026, an estimated $50.9K.
  • Colgate-Palmolive made up 0.05% of Ipswich Investment Management's portfolio in Q2 2026, its #166 holding.
  • Ipswich Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Ipswich Investment Management's Colgate-Palmolive position peaked at $3.63M in Q4 2014.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.